| Q2  2026 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 10.11% |
79,002 |
0.16 |
| ≡ |
Glenn Greenberg - Brave Warrior Advisors |
Reduce 1.53% |
118,155 |
0.16 |
| Q1  2026 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 5.28% |
43,571 |
0.09 |
| ≡ |
Glenn Greenberg - Brave Warrior Advisors |
Reduce 0.46% |
35,986 |
0.05 |
| Q4  2025 |
| ≡ |
Leon Cooperman |
Reduce 16.57% |
139,000 |
0.31 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 11.95% |
111,971 |
0.29 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 9.79% |
9,000 |
0.21 |
| ≡ |
Glenn Greenberg - Brave Warrior Advisors |
Reduce 0.71% |
54,977 |
0.09 |
| Q3  2025 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 38.29% |
57,059 |
1.19 |
| ≡ |
Leon Cooperman |
Reduce 26.34% |
300,000 |
0.53 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 9.26% |
95,588 |
0.22 |
| ≡ |
Glenn Greenberg - Brave Warrior Advisors |
Reduce 0.96% |
75,815 |
0.10 |
| Q2  2025 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 3.73% |
39,992 |
0.10 |
| Q1  2025 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 15.09% |
190,652 |
0.48 |
| ≡ |
Glenn Greenberg - Brave Warrior Advisors |
Reduce 1.26% |
94,034 |
0.11 |
| Q4  2024 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 10.62% |
150,070 |
0.36 |
| ≡ |
Leon Cooperman |
Reduce 0.10% |
315 |
0.00 |
| Q3  2024 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 9.07% |
140,895 |
0.33 |
| Q2  2024 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 16.61% |
309,628 |
0.80 |
| ≡ |
Leon Cooperman |
Reduce 3.75% |
2,357 |
0.00 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 2.61% |
4,000 |
0.13 |
| Q1  2024 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 13.27% |
285,239 |
0.71 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 5.56% |
9,000 |
0.32 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
5,877 |
0.01 |
| Q4  2023 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 42.40% |
4,327 |
0.01 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 0.27% |
5,899 |
0.02 |
| Q3  2023 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 45.76% |
8,607 |
0.01 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 10.84% |
19,700 |
0.51 |
| ≡ |
Glenn Greenberg - Brave Warrior Advisors |
Reduce 0.99% |
52,999 |
0.05 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 0.70% |
15,197 |
0.04 |
| Q2  2023 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 91.27% |
1,900,368 |
55.85 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 17.27% |
3,928 |
0.00 |
| Q1  2023 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 0.84% |
17,697 |
0.04 |
| ≡ |
Glenn Greenberg - Brave Warrior Advisors |
Reduce 0.36% |
18,954 |
0.02 |
| Q4  2022 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 1.72% |
36,827 |
0.08 |
| ≡ |
Glenn Greenberg - Brave Warrior Advisors |
Reduce 1.27% |
68,547 |
0.07 |
| ≡ |
Leon Cooperman |
Sell 100.00% |
340,000 |
0.70 |
| Q1  2022 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
2,426 |
0.00 |
| Q4  2021 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 82.98% |
11,825 |
0.00 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 1.85% |
29,677 |
0.05 |
| Q3  2021 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 26.04% |
564,753 |
1.06 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 8.85% |
1,383 |
0.00 |
| Q2  2021 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 8.34% |
197,269 |
0.31 |
| Q1  2021 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 71.25% |
1,296 |
0.00 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 2.15% |
51,909 |
0.08 |
| Q4  2020 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 84.38% |
9,824 |
0.00 |
| Q1  2020 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 19.53% |
473,480 |
0.58 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
103,799 |
0.06 |
| Q4  2019 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 24.04% |
32,850 |
0.02 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 11.18% |
305,325 |
0.46 |
| Q3  2019 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 10.79% |
330,065 |
0.49 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 3.75% |
5,331 |
0.00 |
| Q2  2019 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 26.87% |
52,180 |
0.03 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 3.67% |
116,630 |
0.16 |
| Q1  2019 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 0.31% |
9,720 |
0.01 |
| Q3  2018 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 5.06% |
169,140 |
0.19 |
| Q2  2018 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 7.54% |
272,265 |
0.35 |
| Q1  2018 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 2.11% |
77,875 |
0.10 |
| Q3  2017 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 1.65% |
61,425 |
0.08 |
| ≡ |
Leon Cooperman |
Sell 100.00% |
944,057 |
0.97 |
| Q4  2016 |
| ≡ |
Leon Cooperman |
Reduce 72.50% |
2,256,328 |
2.21 |
| Q3  2016 |
| ≡ |
Leon Cooperman |
Reduce 3.35% |
107,725 |
0.10 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 0.15% |
4,125 |
0.01 |
| Q4  2015 |
| ≡ |
Leon Cooperman |
Reduce 3.44% |
89,600 |
0.08 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
5,530 |
0.00 |
| Q3  2015 |
| ≡ |
Leon Cooperman |
Reduce 0.73% |
19,200 |
0.02 |